← All Investors
CONMED CORP
CNMD 2.25 06-15-27
Holders
1
Combined Value
$35M
Combined Shares
36,189,000
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Howard Marks - Oaktree Capital | $35M | 0.56% | ~$0.95 | — | Sold Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Howard Marks - Oaktree Capital | SELL | −$4M | ~$0.97 |
| Q4 2025 | Howard Marks - Oaktree Capital | SELL | −$181K | ~$0.96 |
| Q3 2025 | Steve Cohen - Point72 | SOLD OUT | −$67M | ~$0.95 |
| Q3 2025 | Howard Marks - Oaktree Capital | BUY | +$12M | ~$0.95 |
| Q2 2025 | Steve Cohen - Point72 | NEW BUY | +$67M | ~$0.95 |
| Q2 2025 | Israel Englander - Millennium Management | SOLD OUT | −$37M | ~$0.94 |
| Q2 2025 | Howard Marks - Oaktree Capital | BUY | +$9M | ~$0.95 |
| Q1 2025 | Howard Marks - Oaktree Capital | BUY | +$8M | ~$0.94 |
| Q1 2025 | Israel Englander - Millennium Management | SELL | −$471K | ~$0.94 |
| Q4 2024 | Ken Griffin - Citadel Advisors | SOLD OUT | −$31M | ~$0.93 |
| Q4 2024 | Howard Marks - Oaktree Capital | BUY | +$6M | ~$0.93 |
| Q3 2024 | Israel Englander - Millennium Management | SELL | −$10M | ~$0.93 |
| Q3 2024 | Ken Griffin - Citadel Advisors | BUY | +$3M | ~$0.93 |
| Q3 2024 | Howard Marks - Oaktree Capital | NEW BUY | +$633K | ~$0.93 |
| Q2 2024 | Israel Englander - Millennium Management | NEW BUY | +$46M | ~$0.90 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$26M | ~$0.90 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 1 | 36,189,000 | −10.3% | $35M | $0.97 |
| Q4 2025 | 1 | 40,324,000 | −0.5% | $38M | $0.96 |
| Q3 2025 | 1 | 40,513,000 | −58.9% | $38M | $0.95 |
| Q2 2025 | 2 | 98,465,000 | +71.5% | $93M | $0.95 |
| Q1 2025 | 2 | 57,428,000 | +18.6% | $54M | $0.94 |
| Q4 2024 | 2 | 48,419,000 | −35.3% | $45M | $0.93 |
| Q3 2024 | 3 | 74,846,000 | −7.8% | $69M | $0.93 |
| Q2 2024 | 2 | 81,181,000 | — | $72M | $0.90 |